neoX: AI-Driven Biotech Company neoX Raises $10M Pre-A Round
Beijing-based neoX Biotech today announced the completion of a US$10 million pre-A round financing co-led by Vision Plus Capital and Sequoia Capital China. Existing investor Morningside Venture Capital also participated.
Read full article »
Co-Founder & CEO
Michael Chen
NeoX Biotech is a China-based biotechnology company that combines AI with biophysics for the discovery and development of macromolecular drugs to treat cancer.
Read more